HealthStream, Inc. (NASDAQ: HSTM) Stock Competitors & Peer Comparison
See HSTM's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for HSTM and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HSTM | $29.74 | +2.06% | 868.9M | 41.31 | $0.72 | +0.47% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| TEM | $82.58 | -2.94% | 14.5B | -165.16 | -$0.50 | N/A |
| BTSG | $55.69 | -1.50% | 10.9B | 37.88 | $1.47 | N/A |
| BTSGU | $184.31 | -2.19% | 10.8B | 125.46 | $1.47 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HNGE | $95.21 | +2.99% | 7.4B | 50.91 | $1.87 | N/A |
| HQY | $87.25 | -1.35% | 7.3B | 20.39 | $4.28 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
| DOCS | $26.52 | +1.22% | 5B | 17.32 | $1.53 | N/A |
Stock Comparison
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
HSTM vs GEHCV Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas GEHCV's P/E ratio is N/A. In terms of profitability, HSTM's ROE is +0.06%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, HSTM is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check GEHCV's competition here
Tempus AI, Inc. (NASDAQ: TEM)
HSTM vs TEM Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, TEM has a market cap of 14.5B. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while TEM trades at $82.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas TEM's P/E ratio is -165.16. In terms of profitability, HSTM's ROE is +0.06%, compared to TEM's ROE of -0.55%. Regarding short-term risk, HSTM is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check TEM's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
HSTM vs BTSG Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, BTSG has a market cap of 10.9B. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while BTSG trades at $55.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas BTSG's P/E ratio is 37.88. In terms of profitability, HSTM's ROE is +0.06%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, HSTM is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
HSTM vs BTSGU Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, BTSGU has a market cap of 10.8B. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while BTSGU trades at $184.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas BTSGU's P/E ratio is 125.46. In terms of profitability, HSTM's ROE is +0.06%, compared to BTSGU's ROE of +0.15%. Regarding short-term risk, HSTM is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check BTSGU's competition here
Signify Health, Inc. (NYSE: SGFY)
HSTM vs SGFY Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas SGFY's P/E ratio is 70.91. In terms of profitability, HSTM's ROE is +0.06%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, HSTM is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check SGFY's competition here
Hinge Health, Inc. (NYSE: HNGE)
HSTM vs HNGE Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, HNGE has a market cap of 7.4B. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while HNGE trades at $95.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas HNGE's P/E ratio is 50.91. In terms of profitability, HSTM's ROE is +0.06%, compared to HNGE's ROE of +0.30%. Regarding short-term risk, HSTM is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check HNGE's competition here
HealthEquity, Inc. (NASDAQ: HQY)
HSTM vs HQY Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, HQY has a market cap of 7.3B. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while HQY trades at $87.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas HQY's P/E ratio is 20.39. In terms of profitability, HSTM's ROE is +0.06%, compared to HQY's ROE of +0.11%. Regarding short-term risk, HSTM is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check HQY's competition here
R1 RCM Inc. (NASDAQ: RCM)
HSTM vs RCM Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas RCM's P/E ratio is -102.21. In terms of profitability, HSTM's ROE is +0.06%, compared to RCM's ROE of +0.00%. Regarding short-term risk, HSTM is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check RCM's competition here
Doximity, Inc. (NYSE: DOCS)
HSTM vs DOCS Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, DOCS has a market cap of 5B. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while DOCS trades at $26.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas DOCS's P/E ratio is 17.32. In terms of profitability, HSTM's ROE is +0.06%, compared to DOCS's ROE of +0.17%. Regarding short-term risk, HSTM is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check DOCS's competition here
Waystar Holding Corp. (NASDAQ: WAY)
HSTM vs WAY Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, WAY has a market cap of 4.8B. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while WAY trades at $25.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas WAY's P/E ratio is 16.60. In terms of profitability, HSTM's ROE is +0.06%, compared to WAY's ROE of +0.04%. Regarding short-term risk, HSTM is more volatile compared to WAY. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check WAY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
HSTM vs HTFL Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, HTFL has a market cap of 4.3B. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while HTFL trades at $49.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas HTFL's P/E ratio is -24.79. In terms of profitability, HSTM's ROE is +0.06%, compared to HTFL's ROE of -0.42%. Regarding short-term risk, HSTM is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check HTFL's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
HSTM vs ONEM Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas ONEM's P/E ratio is -7.77. In terms of profitability, HSTM's ROE is +0.06%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, HSTM is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
HSTM vs PRVA Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, PRVA has a market cap of 2.5B. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while PRVA trades at $19.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas PRVA's P/E ratio is 93.43. In terms of profitability, HSTM's ROE is +0.06%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, HSTM is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check PRVA's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
HSTM vs NXGN Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas NXGN's P/E ratio is -266.00. In terms of profitability, HSTM's ROE is +0.06%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, HSTM is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check NXGN's competition here
Omnicell, Inc. (NASDAQ: OMCL)
HSTM vs OMCL Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, OMCL has a market cap of 1.6B. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while OMCL trades at $34.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas OMCL's P/E ratio is 17.96. In terms of profitability, HSTM's ROE is +0.06%, compared to OMCL's ROE of +0.03%. Regarding short-term risk, HSTM is more volatile compared to OMCL. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check OMCL's competition here
Certara, Inc. (NASDAQ: CERT)
HSTM vs CERT Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, CERT has a market cap of 1.4B. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while CERT trades at $9.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas CERT's P/E ratio is 23.15. In terms of profitability, HSTM's ROE is +0.06%, compared to CERT's ROE of -0.07%. Regarding short-term risk, HSTM is less volatile compared to CERT. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check CERT's competition here
Agiliti, Inc. (NYSE: AGTI)
HSTM vs AGTI Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas AGTI's P/E ratio is -71.79. In terms of profitability, HSTM's ROE is +0.06%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, HSTM is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check AGTI's competition here
Omada Health (NASDAQ: OMDA)
HSTM vs OMDA Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, OMDA has a market cap of 1.2B. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while OMDA trades at $19.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas OMDA's P/E ratio is 276.71. In terms of profitability, HSTM's ROE is +0.06%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, HSTM is less volatile compared to OMDA. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check OMDA's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
HSTM vs GDRX Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, GDRX has a market cap of 1.1B. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while GDRX trades at $3.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas GDRX's P/E ratio is 10.09. In terms of profitability, HSTM's ROE is +0.06%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, HSTM is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check GDRX's competition here
Teladoc Health, Inc. (NYSE: TDOC)
HSTM vs TDOC Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, TDOC has a market cap of 1B. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while TDOC trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas TDOC's P/E ratio is -5.81. In terms of profitability, HSTM's ROE is +0.06%, compared to TDOC's ROE of -0.13%. Regarding short-term risk, HSTM is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check TDOC's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
HSTM vs CCLDO Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas CCLDO's P/E ratio is N/A. In terms of profitability, HSTM's ROE is +0.06%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, HSTM is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check CCLDO's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
HSTM vs SOPH Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, SOPH has a market cap of 696.3M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while SOPH trades at $8.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas SOPH's P/E ratio is -7.48. In terms of profitability, HSTM's ROE is +0.06%, compared to SOPH's ROE of -1.37%. Regarding short-term risk, HSTM is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check SOPH's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
HSTM vs MPLN-WT Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, HSTM's ROE is +0.06%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, HSTM is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check MPLN-WT's competition here
Phreesia, Inc. (NYSE: PHR)
HSTM vs PHR Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, PHR has a market cap of 619M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while PHR trades at $10.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas PHR's P/E ratio is 35.77. In terms of profitability, HSTM's ROE is +0.06%, compared to PHR's ROE of +0.03%. Regarding short-term risk, HSTM is less volatile compared to PHR. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check PHR's competition here
Accolade, Inc. (NASDAQ: ACCD)
HSTM vs ACCD Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas ACCD's P/E ratio is -3.08. In terms of profitability, HSTM's ROE is +0.06%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, HSTM is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
HSTM vs SHCR Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas SHCR's P/E ratio is -3.76. In terms of profitability, HSTM's ROE is +0.06%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, HSTM is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check SHCR's competition here
NRC Health (NASDAQ: NRC)
HSTM vs NRC Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, NRC has a market cap of 474.4M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while NRC trades at $21.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas NRC's P/E ratio is 25.67. In terms of profitability, HSTM's ROE is +0.06%, compared to NRC's ROE of +0.48%. Regarding short-term risk, HSTM is less volatile compared to NRC. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check NRC's competition here
Evolent Health, Inc. (NYSE: EVH)
HSTM vs EVH Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, EVH has a market cap of 396.5M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while EVH trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas EVH's P/E ratio is 27.12. In terms of profitability, HSTM's ROE is +0.06%, compared to EVH's ROE of -0.99%. Regarding short-term risk, HSTM is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check EVH's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
HSTM vs SLGC Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas SLGC's P/E ratio is -3.04. In terms of profitability, HSTM's ROE is +0.06%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, HSTM is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
HSTM vs SLGCW Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, HSTM's ROE is +0.06%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, HSTM is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
HSTM vs TBRG Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas TBRG's P/E ratio is 9.37. In terms of profitability, HSTM's ROE is +0.06%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, HSTM is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check TBRG's competition here
Carlsmed, Inc. (NASDAQ: CARL)
HSTM vs CARL Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, CARL has a market cap of 383M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while CARL trades at $14.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas CARL's P/E ratio is -9.85. In terms of profitability, HSTM's ROE is +0.06%, compared to CARL's ROE of -0.38%. Regarding short-term risk, HSTM is less volatile compared to CARL. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check CARL's competition here
MultiPlan Corporation (NYSE: MPLN)
HSTM vs MPLN Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas MPLN's P/E ratio is -0.23. In terms of profitability, HSTM's ROE is +0.06%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, HSTM is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check MPLN's competition here
Claritev Corporation (NYSE: CTEV)
HSTM vs CTEV Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, CTEV has a market cap of 368.6M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while CTEV trades at $21.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas CTEV's P/E ratio is -1.27. In terms of profitability, HSTM's ROE is +0.06%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, HSTM is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check CTEV's competition here
So-Young International Inc. (NASDAQ: SY)
HSTM vs SY Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, SY has a market cap of 355.6M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while SY trades at $2.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas SY's P/E ratio is -8.21. In terms of profitability, HSTM's ROE is +0.06%, compared to SY's ROE of -0.16%. Regarding short-term risk, HSTM is more volatile compared to SY. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check SY's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
HSTM vs TRHC Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas TRHC's P/E ratio is -4.27. In terms of profitability, HSTM's ROE is +0.06%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, HSTM is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
HSTM vs SMFR Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas SMFR's P/E ratio is N/A. In terms of profitability, HSTM's ROE is +0.06%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, HSTM is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check SMFR's competition here
American Well Corporation (NYSE: AMWL)
HSTM vs AMWL Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, AMWL has a market cap of 224.3M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while AMWL trades at $13.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas AMWL's P/E ratio is -2.98. In terms of profitability, HSTM's ROE is +0.06%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, HSTM is more volatile compared to AMWL. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check AMWL's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
HSTM vs SPOK Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, SPOK has a market cap of 217.4M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while SPOK trades at $10.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas SPOK's P/E ratio is 17.35. In terms of profitability, HSTM's ROE is +0.06%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, HSTM is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check SPOK's competition here
LifeMD, Inc. (NASDAQ: LFMDP)
HSTM vs LFMDP Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, LFMDP has a market cap of 157.5M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while LFMDP trades at $23.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas LFMDP's P/E ratio is -711.86. In terms of profitability, HSTM's ROE is +0.06%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, HSTM is more volatile compared to LFMDP. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check LFMDP's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
HSTM vs OPRX Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, OPRX has a market cap of 156.9M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while OPRX trades at $8.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas OPRX's P/E ratio is 7.67. In terms of profitability, HSTM's ROE is +0.06%, compared to OPRX's ROE of +0.04%. Regarding short-term risk, HSTM is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check OPRX's competition here
LifeMD, Inc. (NASDAQ: LFMD)
HSTM vs LFMD Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, LFMD has a market cap of 139.3M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while LFMD trades at $2.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas LFMD's P/E ratio is -5.76. In terms of profitability, HSTM's ROE is +0.06%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, HSTM is less volatile compared to LFMD. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check LFMD's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
HSTM vs CPSI Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas CPSI's P/E ratio is -183.80. In terms of profitability, HSTM's ROE is +0.06%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, HSTM is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check CPSI's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
HSTM vs HCAT Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, HCAT has a market cap of 129.3M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while HCAT trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas HCAT's P/E ratio is 8.75. In terms of profitability, HSTM's ROE is +0.06%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, HSTM is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check HCAT's competition here
Augmedix, Inc. (NASDAQ: AUGX)
HSTM vs AUGX Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas AUGX's P/E ratio is -4.99. In terms of profitability, HSTM's ROE is +0.06%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, HSTM is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check AUGX's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
HSTM vs DH Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, DH has a market cap of 98.1M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while DH trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas DH's P/E ratio is 3.58. In terms of profitability, HSTM's ROE is +0.06%, compared to DH's ROE of -0.79%. Regarding short-term risk, HSTM is more volatile compared to DH. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check DH's competition here
CareCloud, Inc. (NASDAQ: CCLD)
HSTM vs CCLD Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, CCLD has a market cap of 88.4M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while CCLD trades at $2.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas CCLD's P/E ratio is 8.00. In terms of profitability, HSTM's ROE is +0.06%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, HSTM is less volatile compared to CCLD. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check CCLD's competition here
SCWorx Corp. (NASDAQ: WORX)
HSTM vs WORX Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, WORX has a market cap of 88M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while WORX trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas WORX's P/E ratio is -6.40. In terms of profitability, HSTM's ROE is +0.06%, compared to WORX's ROE of -0.35%. Regarding short-term risk, HSTM is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check WORX's competition here
Forian Inc. (NASDAQ: FORA)
HSTM vs FORA Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas FORA's P/E ratio is -24.11. In terms of profitability, HSTM's ROE is +0.06%, compared to FORA's ROE of -0.17%. Regarding short-term risk, HSTM is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
HSTM vs CCLDP Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas CCLDP's P/E ratio is N/A. In terms of profitability, HSTM's ROE is +0.06%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, HSTM is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check CCLDP's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
HSTM vs SNCE Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas SNCE's P/E ratio is -0.27. In terms of profitability, HSTM's ROE is +0.06%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, HSTM is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
HSTM vs AKLI Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas AKLI's P/E ratio is -0.71. In terms of profitability, HSTM's ROE is +0.06%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, HSTM is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
HSTM vs SHLT Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas SHLT's P/E ratio is -3.87. In terms of profitability, HSTM's ROE is +0.06%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, HSTM is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
HSTM vs SHCRW Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, HSTM's ROE is +0.06%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, HSTM is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMD)
HSTM vs ONMD Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, ONMD has a market cap of 31.3M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while ONMD trades at $5.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas ONMD's P/E ratio is -34.37. In terms of profitability, HSTM's ROE is +0.06%, compared to ONMD's ROE of +2.35%. Regarding short-term risk, HSTM is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check ONMD's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
HSTM vs ONMDW Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, ONMDW has a market cap of 26.6M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas ONMDW's P/E ratio is -0.19. In terms of profitability, HSTM's ROE is +0.06%, compared to ONMDW's ROE of +2.35%. Regarding short-term risk, HSTM is less volatile compared to ONMDW. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
HSTM vs STRM Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas STRM's P/E ratio is -2.40. In terms of profitability, HSTM's ROE is +0.06%, compared to STRM's ROE of -0.65%. Regarding short-term risk, HSTM is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
HSTM vs RNLX Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas RNLX's P/E ratio is -0.33. In terms of profitability, HSTM's ROE is +0.06%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, HSTM is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
HSTM vs LIFW Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas LIFW's P/E ratio is -0.02. In terms of profitability, HSTM's ROE is +0.06%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, HSTM is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check LIFW's competition here
Babylon Holdings Limited (NYSE: BBLN)
HSTM vs BBLN Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas BBLN's P/E ratio is -0.04. In terms of profitability, HSTM's ROE is +0.06%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, HSTM is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check BBLN's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
HSTM vs BFRG Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, BFRG has a market cap of 12M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while BFRG trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas BFRG's P/E ratio is -1.41. In terms of profitability, HSTM's ROE is +0.06%, compared to BFRG's ROE of -1.50%. Regarding short-term risk, HSTM is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check BFRG's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
HSTM vs HCTI Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, HCTI has a market cap of 9.9M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while HCTI trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas HCTI's P/E ratio is -0.08. In terms of profitability, HSTM's ROE is +0.06%, compared to HCTI's ROE of -0.56%. Regarding short-term risk, HSTM is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check HCTI's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
HSTM vs ETAO Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas ETAO's P/E ratio is -0.01. In terms of profitability, HSTM's ROE is +0.06%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, HSTM is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check ETAO's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
HSTM vs MGRX Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, MGRX has a market cap of 7.7M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while MGRX trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas MGRX's P/E ratio is -0.33. In terms of profitability, HSTM's ROE is +0.06%, compared to MGRX's ROE of -1.06%. Regarding short-term risk, HSTM is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check MGRX's competition here
Aclarion, Inc. (NASDAQ: ACON)
HSTM vs ACON Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, ACON has a market cap of 6.9M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while ACON trades at $2.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas ACON's P/E ratio is -0.27. In terms of profitability, HSTM's ROE is +0.06%, compared to ACON's ROE of -0.59%. Regarding short-term risk, HSTM is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check ACON's competition here
UpHealth, Inc. (NYSE: UPH-WT)
HSTM vs UPH-WT Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, HSTM's ROE is +0.06%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, HSTM is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check UPH-WT's competition here
UpHealth, Inc. (NYSE: UPH)
HSTM vs UPH Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas UPH's P/E ratio is -0.07. In terms of profitability, HSTM's ROE is +0.06%, compared to UPH's ROE of -1.05%. Regarding short-term risk, HSTM is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check UPH's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
HSTM vs PEAR Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas PEAR's P/E ratio is -0.08. In terms of profitability, HSTM's ROE is +0.06%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, HSTM is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
HSTM vs PEARW Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas PEARW's P/E ratio is -0.00. In terms of profitability, HSTM's ROE is +0.06%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, HSTM is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
HSTM vs OTRK Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas OTRK's P/E ratio is -0.02. In terms of profitability, HSTM's ROE is +0.06%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, HSTM is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check OTRK's competition here
Bullfrog AI Holdings, Inc. Warrants (NASDAQ: BFRGW)
HSTM vs BFRGW Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, BFRGW has a market cap of 2.3M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while BFRGW trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas BFRGW's P/E ratio is -0.38. In terms of profitability, HSTM's ROE is +0.06%, compared to BFRGW's ROE of -1.50%. Regarding short-term risk, HSTM is less volatile compared to BFRGW. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check BFRGW's competition here
CareMax, Inc. (NASDAQ: CMAX)
HSTM vs CMAX Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas CMAX's P/E ratio is -0.00. In terms of profitability, HSTM's ROE is +0.06%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, HSTM is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check CMAX's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
HSTM vs LIFWZ Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, HSTM's ROE is +0.06%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, HSTM is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check LIFWZ's competition here
VSee Health, Inc. (NASDAQ: VSEE)
HSTM vs VSEE Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, VSEE has a market cap of 1.2M. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while VSEE trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas VSEE's P/E ratio is -3.80. In terms of profitability, HSTM's ROE is +0.06%, compared to VSEE's ROE of -4.01%. Regarding short-term risk, HSTM is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check VSEE's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
HSTM vs VSEEW Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, VSEEW has a market cap of 560.3K. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, HSTM's ROE is +0.06%, compared to VSEEW's ROE of -4.01%. Regarding short-term risk, HSTM is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check VSEEW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
HSTM vs MSPRZ Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, HSTM's ROE is +0.06%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, HSTM is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERNW)
HSTM vs KERNW Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas KERNW's P/E ratio is -0.00. In terms of profitability, HSTM's ROE is +0.06%, compared to KERNW's ROE of -0.20%. Regarding short-term risk, HSTM is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check KERNW's competition here
Akerna Corp. (NASDAQ: KERN)
HSTM vs KERN Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas KERN's P/E ratio is -0.01. In terms of profitability, HSTM's ROE is +0.06%, compared to KERN's ROE of -0.20%. Regarding short-term risk, HSTM is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check KERN's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
HSTM vs LIFWW Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas LIFWW's P/E ratio is N/A. In terms of profitability, HSTM's ROE is +0.06%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, HSTM is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check LIFWW's competition here
CareMax, Inc. (NASDAQ: CMAXW)
HSTM vs CMAXW Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas CMAXW's P/E ratio is N/A. In terms of profitability, HSTM's ROE is +0.06%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, HSTM is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check CMAXW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
HSTM vs ZCMD Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, ZCMD has a market cap of 31.3K. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while ZCMD trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas ZCMD's P/E ratio is -0.03. In terms of profitability, HSTM's ROE is +0.06%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, HSTM is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check ZCMD's competition here
Aclarion, Inc. (NASDAQ: ACONW)
HSTM vs ACONW Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, ACONW has a market cap of 26.7K. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while ACONW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas ACONW's P/E ratio is N/A. In terms of profitability, HSTM's ROE is +0.06%, compared to ACONW's ROE of -0.59%. Regarding short-term risk, HSTM is less volatile compared to ACONW. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check ACONW's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
HSTM vs SMFRW Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas SMFRW's P/E ratio is N/A. In terms of profitability, HSTM's ROE is +0.06%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, HSTM is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check SMFRW's competition here
NantHealth, Inc. (NASDAQ: NH)
HSTM vs NH Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, NH has a market cap of 0. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas NH's P/E ratio is -0.12. In terms of profitability, HSTM's ROE is +0.06%, compared to NH's ROE of +0.35%. Regarding short-term risk, HSTM is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check NH's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
HSTM vs AFFX Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, AFFX has a market cap of 0. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas AFFX's P/E ratio is N/A. In terms of profitability, HSTM's ROE is +0.06%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, HSTM is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check AFFX's competition here
CareCloud, Inc. (NASDAQ: MTBC)
HSTM vs MTBC Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas MTBC's P/E ratio is N/A. In terms of profitability, HSTM's ROE is +0.06%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, HSTM is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check MTBC's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
HSTM vs NAVA Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas NAVA's P/E ratio is N/A. In terms of profitability, HSTM's ROE is +0.06%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, HSTM is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for HSTM.Check NAVA's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
HSTM vs MTBCO Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas MTBCO's P/E ratio is N/A. In terms of profitability, HSTM's ROE is +0.06%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, HSTM is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check MTBCO's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
HSTM vs IMS Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, IMS has a market cap of 0. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas IMS's P/E ratio is N/A. In terms of profitability, HSTM's ROE is +0.06%, compared to IMS's ROE of +0.27%. Regarding short-term risk, HSTM is more volatile compared to IMS. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check IMS's competition here
Castlight Health, Inc. (NYSE: CSLT)
HSTM vs CSLT Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas CSLT's P/E ratio is -37.27. In terms of profitability, HSTM's ROE is +0.06%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, HSTM is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check CSLT's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
HSTM vs CNVY Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas CNVY's P/E ratio is -71.50. In terms of profitability, HSTM's ROE is +0.06%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, HSTM is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check CNVY's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
HSTM vs KURIU Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, KURIU has a market cap of 0. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas KURIU's P/E ratio is N/A. In terms of profitability, HSTM's ROE is +0.06%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, HSTM is less volatile compared to KURIU. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check KURIU's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
HSTM vs CHNGU Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas CHNGU's P/E ratio is N/A. In terms of profitability, HSTM's ROE is +0.06%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, HSTM is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check CHNGU's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
HSTM vs MTBCP Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas MTBCP's P/E ratio is N/A. In terms of profitability, HSTM's ROE is +0.06%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, HSTM is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check MTBCP's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
HSTM vs MSPRV Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas MSPRV's P/E ratio is N/A. In terms of profitability, HSTM's ROE is +0.06%, compared to MSPRV's ROE of N/A. Regarding short-term risk, HSTM is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for HSTM.Check MSPRV's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
HSTM vs CHNG Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas CHNG's P/E ratio is -152.72. In terms of profitability, HSTM's ROE is +0.06%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, HSTM is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check CHNG's competition here
Cerner Corporation (NASDAQ: CERN)
HSTM vs CERN Comparison September 2026
HealthStream, Inc. (NASDAQ: HSTM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HSTM stands at 868.9M. In comparison, CERN has a market cap of 0. Regarding current trading prices, HSTM is priced at $29.74 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HSTM currently has a P/E ratio of 41.31, whereas CERN's P/E ratio is 55.84. In terms of profitability, HSTM's ROE is +0.06%, compared to CERN's ROE of +0.14%. Regarding short-term risk, HSTM is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for HSTM.Check CERN's competition here